Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01578499
Brief Title: A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study) (ALCANZA)

First Submitted : March 27, 2012
First Submitted that Met QC Criteria : April 13, 2012
First Posted : April 17, 2012 (Estimate)

Results First Submitted : December 9, 2017
Results First Submitted that Met QC Criteria : February 19, 2018
Results First Posted : March 16, 2018

Certification/Extension First Submitted : February 2, 2017
Certification/Extension First Submitted that Met QC Criteria : February 2, 2017
Certification/Extension First Posted : February 3, 2017 (Estimate)

Last Update Submitted that Met QC Criteria : December 16, 2020
Last Update Posted : January 5, 2021